Inhibition of pro-inflammatory cytokines and inducible nitric oxide by extract of Emilia sonchifolia L. aerial parts

Immunopharmacology and Immunotoxicology

Volumn 34, Issue 6, 2012, Pages 925-931

  Nworu, Chukwuemeka S ^a   Akah, Peter A ^a   Okoye, Festus B C ^b,c   Esimone, Charles O ^b  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cytokines; Emilia sonchifolia; Inducible nitric oxide; Interleukin (IL 1 ); Pro inflammatory mediators; Tumour necrosis factor (TNF)

Indexed keywords

EMILIA SONCHIFOLIA PLANT EXTRACT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMILIA SONCHIFOLIA; IN VITRO STUDY; MACROPHAGE; MEDICINAL PLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTERACEAE; BONE MARROW CELLS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; TUMOR NECROSIS FACTOR-ALPHA;

ASTERACEAE; EMILIA SONCHIFOLIA; MUS; RODENTIA;

EID: 84868102160     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2012.696202     Document Type: Article

References (49)

1. Spelman, K., Burns, J., Nichols, D., Winters, N., Ottersberg, S., Tenborg, M. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev 2006, 11, 128-150.
2. Iwu MM. Igbo traditional medicine. Nsukka: Institute of African Studies, University of Nigeria 1986; p. 30-35.
3. Nadkarni KM, Nadkarni AK. Indian Materia Medica. Bombay: Popular Prakashanm, 1976.
4. Shylesh, B.S., Padikkala, J. In vitro cytotoxic and antitumor property of Emilia sonchifolia (L.) DC in mice. J Ethnopharmacol 2000, 73, 495-500.
5. Warrier P.K., Nambiar V.P.K., Ramankutty C. In: Vaidyarathnam P.S., editor. Indian medicinal plants, a compendium of 500 species, vol. 2. Madras: Varier's Orient Longman Ltd, 1994; p. 372-373.
6. Cheng, D., Röder, E. [Pyrrolizidine Alkaloids from Emilia sonchifolia.]. Planta Med 1986, 6, 484-486.
7. Srinivasan K.K., Subramanian S.S. Phytochemical screening of Emilia sonchifolia. Fitoterapia 1980; 51: 241-242.
8. Couto, V.M., Vilela, F.C., Dias, D.F., Dos Santos, M.H., Soncini, R., Nascimento, C.G., Giusti-Paiva, A. Antinociceptive effect of extract of Emilia sonchifolia in mice. J Ethnopharmacol 2011, 134, 348-353.
9. Muko, K.N., Ohiri, F.C. A preliminary study on the antiinflammatory properties of Emilia sonchifolia leaf extracts. Fitoterapia 2000, 71, 65-68.
10. Shylesh B.S., Padikkala J. Antioxidant and anti-inflammatory activity of Emilia sonchifolia. Fitoterapia 1999; 70, 275-278.
11. Tripathi, S., Bruch, D., Kittur, D.S. Ginger extract inhibits LPS induced macrophage activation and function. BMC Complement Altern Med 2008, 8, 1.
12. Kim, S.J., Jeong, H.J., Moon, P.D., Lee, K.M., Lee, H.B., Jung, H.J., Jung, S.K., Rhee, H.K., Yang, D.C., Hong, S.H., Kim, H.M. Antiinflammatory activity of gumiganghwaltang through the inhibition of nuclear factor-κ B activation in peritoneal macrophages. Biol Pharm Bull 2005, 28, 233-237.
13. Evans W.C. Trease and Evans pharmacognosy 14th edition. London: WB Saunders Company Limited 1998; pp. 15-16.
14. Harborne J.B., Harborne A.J. (Eds.) 1998. Phytochemical methods: a guide to modern techniques of plant analysis. London: Kluwer Academic Publishers
15. Lin, H., Chen, C., Chen, B.D. Resistance of bone marrow-derived macrophages to apoptosis is associated with the expression of X-linked inhibitor of apoptosis protein in primary cultures of bone marrow cells. Biochem J 2001, 353, 299-306.
16. Weischenfeldt J., Porse B. Bone marrow-derived macrophages (BMM): Isolation and applications. Cold Spring Harbor Protocols; 2008. Available at: http:// cshprotocols.cshlp.org/cgi/content/full/2008/13/pdb.prot5080.
17. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65, 55-63.
18. Krakauer, T. Molecular therapeutic targets in inflammation: cyclooxygenase and NF-κB. Curr Drug Targets Inflamm Allergy 2004, 3, 317-324.
19. Esposito, K., Giugliano, D. The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis 2004, 14, 228-232.
20. Ohshima, H., Bartsch, H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994, 305, 253-264.
21. Hong Y.H., Chao W.W., Chen M.L., Lin B.F. Ethyl acetate extracts of alfalfa (Medicago sativa L.) sprouts inhibit lipopolysaccharideinduced inflammation in vitro and in vivo. J Biomed Sci 2009; 16:64.
22. Pearson, W., Fletcher, R.S., Kott, L.S., Hurtig, M.B. Protection against LPS-induced cartilage inflammation and degradation provided by a biological extract of Mentha spicata. BMC Complement Altern Med 2010, 10, 19.
23. Raza, A. Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes. Microsc Res Tech 2000, 50, 229-235.
24. Wheeler, A.P., Bernard, G.R. Treating patients with severe sepsis. N Engl J Med 1999, 340, 207-214.
25. Turini, M.E., DuBois, R.N. Cyclooxygenase-2: a therapeutic target. Annu Rev Med 2002, 53, 35-57.
26. Korhonen, R., Lahti, A., Kankaanranta, H., Moilanen, E. Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 2005, 4, 471-479.
27. Duval, D.L., Miller, D.R., Collier, J., Billings, R.E. Characterization of hepatic nitric oxide synthase: identification as the cytokineinducible form primarily regulated by oxidants. Mol Pharmacol 1996, 50, 277-284.
28. Adams, L.B., Hibbs, J.B. Jr, Taintor, R.R., Krahenbuhl, J.L. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol 1990, 144, 2725-2729.
29. Stuehr, D.J., Nathan, C.F. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989, 169, 1543-1555.
30. Suk, K., Somers, S.D., Erickson, K.L. Regulation of murine macrophage function by IL-4: IL-4 and IFN-κ differentially regulate macrophage tumoricidal activation. Immunology 1993, 80, 617-624.
31. Guzik, T.J., Korbut, R., Adamek-Guzik, T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003, 54, 469-487.
32. Moncada, S., Palmer, R.M., Higgs, E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43, 109-142.
33. Snyder, S.H., Bredt, D.S. Biological roles of nitric oxide. Sci Am 1992, 266, 68-71, 74.
34. Liu, S.F., Ye, X., Malik, A.B. Inhibition of NF-κB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes. Circulation 1999, 100, 1330-1337.
35. Ziegler-Heitbrock, H.W., Sternsdorf, T., Liese, J., Belohradsky, B., Weber, C., Wedel, A., Schreck, R., Bäuerle, P., Ströbel, M. Pyrrolidine dithiocarbamate inhibits NF-κ B mobilization and TNF production in human monocytes. J Immunol 1993, 151, 6986-6993.
36. Hajri, A., Metzger, E., Vallat, F., Coffy, S., Flatter, E., Evrard, S., Marescaux, J., Aprahamian, M. Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies. Br J Cancer 1998, 78, 841-849.
37. Nascimento, F.R., Ribeiro-Dias, F., Russo, M. Cytotoxic activity of BCG-activated macrophages against L929 tumor cells is nitric oxide-dependent. Braz J Med Biol Res 1998, 31, 1593-1596.
38. Akira, S., Uematsu, S., Takeuchi, O. Pathogen recognition and innate immunity. Cell 2006, 124, 783-801.
39. Beutler, B., Jiang, Z., Georgel, P., Crozat, K., Croker, B., Rutschmann, S., Du, X., Hoebe, K. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol 2006, 24, 353-389.
40. Creagh, E.M., O'Neill, L.A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 2006, 27, 352-357.
41. Beutler, B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004, 430, 257-263.
42. Yamamoto, M., Akira, S. [TIR domainYcontaining adaptors regulate TLRmediated signaling pathways]. Nippon Rinsho 2004, 62, 2197-2203.
43. Iwalewa E.O., McGaw L.J., Naidoo V., Eloff J.N. Inflammation: the foundation of diseases and disorders. A review of phytomedicines of South African origin used to treat pain and inflammatory conditions. Afr J Biotech. 2007; 6: 2868-2885.
44. Soliman, K.F., Mazzio, E.A. In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proc Soc Exp Biol Med 1998, 218, 390-397.
45. Wagner H. (1990). Search for plant derived natural products with immunostimulatory activity (recent advances). Pure Appl Chem, 62: 1217-1222.
46. Lija, Y., Biju, P.G., Reeni, A., Cibin, T.R., Sahasranamam, V., Abraham, A. Modulation of selenite cataract by the flavonoid fraction of Emilia sonchifolia in experimental animal models. Phytother Res 2006, 20, 1091-1095.
47. Ferriola, P.C., Cody, V., Middleton, E. Jr. Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 1989, 38, 1617-1624.
48. Kim, H.P., Son, K.H., Chang, H.W., Kang, S.S. Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci 2004, 96, 229-245.
49. Xagorari, A., Roussos, C., Papapetropoulos, A. Inhibition of LPSstimulated pathways in macrophages by the flavonoid luteolin. Br J Pharmacol 2002, 136, 1058-1064.